During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

Tammy Miller has been a wealth and philanthropy advisor for over 30 years. As executive director of the Aldarra Foundation, ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

Phuong Tran, RN, OCN, is a nurse manager at Fred Hutch at EvergreenHealth in Kirkland, Washington who has spent her entire 35-year career at Fred Hutch Cancer Center. There is one thing that fuels her ...

Faculty profile for Dr. Christopher D. Blosser. Dr. Blosser is a transplant nephrologist and medical director of the Cancer and Organ Transplant Clinic (COTC) at Fred Hutch Cancer Center. He is also ...

The CSRN is a multi-center effort, funded by the National Cancer Institute, and is the first large-scale network to focus on cancer screening. Fred Hutch Cancer Center serves as the coordinating and ...

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

There is much to consider when it comes to using the new semaglutide drugs for weight loss, especially for cancer patients. Fred Hutch experts weight in.

We know they’re common and annoying, and in the immunocompromised or the unlucky, sometimes deadly. But three years after COVID-19 rocked the world, are we now learning viruses are more of a threat ...